Waldenström's macroglobulinemia epidemiology and demographics
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia epidemiology and demographics |
FDA on Waldenström's macroglobulinemia epidemiology and demographics |
CDC on Waldenström's macroglobulinemia epidemiology and demographics |
Waldenström's macroglobulinemia epidemiology and demographics in the news |
Blogs on Waldenström's macroglobulinemia epidemiology and demographics |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Of all cancers involving the lymphocytes, 1% of cases are WM.[1]
WM is a rare disorder, with fewer than 1,500 cases occurring in the United States annually.[2] The median age of onset of WM is between 60 and 65 years, with some cases occurring in late teens.[2][3]
References
- ↑ Turgeon, Mary Louise (2005). Clinical hematology: theory and procedures. Hagerstown, MD: Lippincott Williams & Wilkins. p. 283. ISBN 0-7817-5007-5.
Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and Lymphoid Tissues. 2001, p. 2001.)
- ↑ 2.0 2.1 Invalid
<ref>
tag; no text was provided for refs namedCheson
- ↑ Raje N, Hideshima T, Anderson KC (2003). "Plasma Cell Tumors". In Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS. Holland-Frei Cancer Medicine (6th ed.). New York, NY: B.C. Decker. ISBN 1-55009-213-8.